Arena Pharmaceuticals, Inc. Shareholders' Equity
Arena Pharmaceuticals, Inc. had Shareholders' Equity of $673.24 million as of 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-02-23
- 2021-12-31: Stockholders' Equity Attributable to Parent $673.24M.
- 2021-09-30: Stockholders' Equity Attributable to Parent $800.72M.
- 2021-06-30: Stockholders' Equity Attributable to Parent $971.08M.
- 2021-03-31: Stockholders' Equity Attributable to Parent $1.09B.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2021-12-31 | $673.24M 10-K · filed 2022-02-23 | |
| 2021-09-30 | $800.72M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $971.08M 10-Q · filed 2021-11-04 | |
| 2021-03-31 | $1.09B 10-Q · filed 2021-11-04 | |
| 2020-12-31 | $1.08B 10-K · filed 2022-02-23 | |
| 2020-09-30 | $1.17B 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $1.24B 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $988.49M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $1.07B 10-K · filed 2022-02-23 | |
| 2019-09-30 | $1.15B 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $1.20B 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $1.24B 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $606.26M 10-K · filed 2022-02-23 | |
| 2018-09-30 | $531.32M 10-Q · filed 2019-11-08 | $531.32M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $558.84M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $584.13M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $207.14M 10-Q · filed 2019-11-08 | |
| 2017-09-30 | $218.67M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $82.78M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $26.61M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $39.90M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $3.33M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $13.56M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $37.56M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $53.54M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $82.20M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $107.36M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $128.93M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $47.34M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $76.29M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $102.84M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $126.06M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $91.86M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $112.07M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $124.94M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $80.42M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $98.64M 10-K · filed 2016-02-29 | |
| 2012-09-30 | $117.27M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $107.78M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $44.83M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $10.56M 10-K · filed 2015-03-02 | |
| 2011-09-30 | $35.14M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $60.16M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $80.02M 10-K · filed 2014-03-03 | |
| 2009-12-31 | $74.57M 10-K · filed 2013-03-01 | |
| 2008-12-31 | $117.63M 10-K · filed 2012-03-15 |